(Reuters) -Billionaire Richard Li's efforts to expand his insurance business into mainland China have been put on hold after Beijing reacted with fury to his father Li Ka-shing's plan to sell a suite ...

CK Life Sciences, the biotech arm of Hong Kong billionaire Li Ka-shing, has agreed to merge a Canadian drug development unit, WEX Pharmaceuticals, with Nasdaq-listed Virios Therapeutics. CK Life ...

China’s biggest shipping company is set to join the global consortium that’s acquiring Hong Kong tycoon Li Ka-shing’s overseas ports, and is requesting a powerful role in the group in order to secure ...

CKI is the first foreign company to take advantage of the U.K.’s biggest listing rule overhaul in three decades. CK Infrastructure Holdings (CKI), part of the global business empire of Hong Kong’s ...

Li Ka-shing and his family set in motion a series of deals this year that stand to completely transform his business empire.

To some he is the “Cockroach King,” accused of being a closet supporter of Hong Kong’s pro-democracy movement and a traitor to China. To others — namely the Trump administration and its allies — he is ...

(Reuters) -China has instructed state-owned firms to pause new deals with businesses linked to Hong Kong billionaire Li Ka-shing and his family after his plan to sell two ports in Panama to a ...

Richard Li, the son of Asia's richest man, Li Ka-shing, is known for straying from the family business and venturing into sectors on his own. The WSJ's Deborah Kan speaks to Dow Jones' Jeffery Ng ...

HONG KONG (Reuters) - His name is synonymous with the hard-driving business style in his adopted city of Hong Kong, and now Li Ka-shing will also become a force in Britain after offering to buy one of ...

HONG KONG — Li Ka-shing, a high school dropout who got his start selling plastic flowers, will retire from the empire that made him Hong Kong’s richest man, he said Friday, bringing a symbolic end to ...